Navigation Links
33rd ESMO Congress in Stockholm, 12-16 September 2008
Date:9/5/2008

y inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to Prof. Michael Friedlander from Australia presenting the results of an international collaborative trial involving patients with recurrent ovarian, fallopian tube or peritoneal carcinoma.

Late-breaking data: New treatment option for women with recurrent ovarian

cancer

(Embargoed until Monday, 15 September 2008, 16:30 CEST)

Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results. The combination, which importantly does not include a platinum drug, challenges the current standard of treatment for women whose cancer recurs at least 6 months after first-line treatment, said Associate Professor Bradley J. Monk from the University of California Irvine Medical Center.

Supportive care

Adding iron to darbepoetin therapy helps with chemotherapy-induced

anaemia

(Embargoed until Monday, 15 September 2008, 08:45 CEST)

For patients suffering from chemotherapy-induced anaemia, adding intravenous iron to treatments with the drug darbepoietin alfa results in better haematologic response, and a faster improvement in the condition, US researcher Michael Auerbach reports.

Patient seminar

An estimated 25 million people alive today have survived cancer, a number that is likely to grow substantially in the future thanks in part to improved treatments such as personalised therapies, leading experts will tell patients at the 7th ESMO Patient Seminar. Providing appropriate care to these survivors, many of whom face lingering medical complications and psychological repercussions, will pose a difficult challenge for healthcare systems around the world.

Further late-breaking data available close to the Congress...

The conference full program is available at

SOURCE ESMO European Society for Medical Oncology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site
9. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. The Library of Congress in your wrist watch?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2
... Institute of Standards and Technology (NIST) wanted was a ... copolymers or BCPs (chemically distinct polymers linked together) in ... to the microelectronics industry. What they got for their ... Letters,* was an unexpected bonus: a unique annealing process ...
... 2007, NEW YORK, Sept. 14 The following is being issued by,Pfizer ... will discuss the global burden ... cause of mortality worldwide. A panel of experts will explore the ... and treatment, the development of ...
... New Jersey, September 14, Rosetta Genomics Ltd (Nasdaq: ... microRNA-based diagnostics and therapeutics, announced,today that Amir Avniel, ... conference on Thursday, September 20, at 5:00 pm ... A live audio webcast of the presentation ...
Cached Biology Technology:NIST team develops novel method for nanostructured polymer thin films 2Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States 2Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference 2
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new Match-in-Sensor™ ... hardware encapsulated fingerprint sensor and matching solution. ... literally off the grid, isolating fingerprint image ... the fingerprint sensor to provide ultimate protection ...
(Date:7/8/2015)... NEW YORK , July 8, 2015  BD ... announced BD & Guidepoint Mentor, a new ... to Guidepoint,s expert network services. BD ... technologies to improve healthcare delivery and outcomes and, with ... start-up entrepreneur will be able to directly engage with ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... (Dec. 11, 2012) Here,s a reason to be glad about ... rechargeable battery. Scientists at Rice University and the City College ... tinctorum, is a good source of purpurin, an organic dye that ... batteries. The plant has been used since ancient times to create ...
... IDTA) CEO Yaacov Shoham today announced that Zillion International ... in much detail IDenta Corp. and its products. ... Senior Business Editor ZILLION Media BV ... following link: http://www.yousendit.com/download/WUJZY051UzdEa1ZqQTlVag IDenta,s ...
... molecules without the need for the standard pre-sequencing workflow ... researchers generated sequence data using considerably less DNA than ... than one nanogram of DNA; 500 times less DNA ... collections of DNA fragments derived from genomic samples using ...
Cached Biology News:Rice cultivates green batteries from plant 2Rice cultivates green batteries from plant 3International Drug & Explosives Detection Company IDenta Corp. Article to be Published by Zillion International 2No need to prepare 2
... ATP-Free using Mo Bio luciferase assay. Mo Bio ... that will allow you to certify your products ... enable you to deliver them to your customers ... detection limit is 3.5 x 10-12 /l, which ...
... Concept in Microarrays: Biomedical Photometrics Inc. (Waterloo, ... (Jena, Germany) have collaborated to develop a ... System. The DNAscope AT is based ... DNAscope AT automatically reads up to six ...
... a comprehensive kinase analysis service utilizing ... peptide microarrays synthesized on Paraflo microfluidic ... quantitative measurement of kinase kinetic activities, ... service includes preparation of your kinase ...
... The JNK (c-Jun NH2-terminal kinase) signal ... identified MAP kinase pathways in mammals. ... to environmental stress, is associated with ... and is implicated in the immune ...
Biology Products: